5-Fluorouracil infusion reduces gut-associated lymphoid tissue cell number and mucosal immunoglobulin a levels

Journal of Parenteral and Enteral Nutrition

Volumn 29, Issue 6, 2005, Pages 395-400

  Nagayoshi, Hidetoshi ^a   Fukatsu, Kazuhiko ^a   Ueno, Chikara ^a   Hara, Etsuko ^a   Maeshima, Yoshinori ^a   Omata, Jiro ^a   Hiraide, Hoshio ^a   Mochizuki, Hidetaka ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD4 ANTIGEN; CD8 ANTIGEN; FLUOROURACIL; IMMUNOGLOBULIN A; SODIUM CHLORIDE; ANTINEOPLASTIC ANTIMETABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CANNULATION; CONTROLLED STUDY; DRUG INFUSION; EFFECTOR CELL; FOOD INTAKE; GASTROINTESTINAL SYMPTOM; IMMUNOGLOBULIN BLOOD LEVEL; INTESTINE LYMPHATIC TISSUE; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; LAMINA PROPRIA; LYMPHOCYTE COUNT; MALE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DRUG EFFECT; FLOW CYTOMETRY; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; LYMPHOCYTE; LYMPHOID TISSUE; PHYSIOLOGY; RANDOMIZATION; SMALL INTESTINE; TOTAL PARENTERAL NUTRITION;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; FLUOROURACIL; IMMUNOGLOBULIN A; INTESTINAL MUCOSA; INTESTINE, SMALL; LYMPHOCYTES; LYMPHOID TISSUE; MALE; MICE; MICE, INBRED ICR; PARENTERAL NUTRITION, TOTAL; RANDOM ALLOCATION;

EID: 33645744220     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607105029006395     Document Type: Article

References (22)

1. Stewart FM, Temeles D, Lowry P, Thraves T, Grosh WW, Quesenberry PJ. Post-5-fluorouracil human marrow: stem cell characteristics and renewal properties after autologous marrow transplantation. Blood. 1993;81:2283-2289.
2. Spijkervet FK, Sonis ST. New frontiers in the management of chemotherapy-induced mucositis. Curr Opin Oncol. 1998;10(suppl 1):S23-S27.
3. Tisdale MJ. Cancer cachexia. Anticancer Drugs. 1993;4:115-125.
4. Dikken C, Sitzia J. Patients' experiences of chemotherapy: side-effects associated with 5-fluorouracil+ folinic acid in the treatment of colorectal cancer. J Clin Nurs. 1998;7:371-379.
5. Tsuji E, Hiki N, Kaminishi M, et al. Simultaneous onset of acute inflammatory response, sepsis-like symptoms and intestinal mucosal injury after cancer chemotherapy. Int J Cancer. 2003;107:303-308.
6. Nagahama S, Korenaga D, Honda M, Inutsuka S, Sugimachi K. Assessment of the intestinal permeability after a gastrectomy and the oral administration of anticancer drugs in rats: nitric oxide release in response to gut injury. Surgery. 2002;131(1 suppl):S92-S97.
7. Banke A, Balazs H, Holt P, et al. Mechanism of lovastatin-induced apoptosis in intestinal epithelial cells. Carcinogenesis. 2002;23:521-528.
8. Kelsall B, Strober W. Gut-associated lymphoid tissue. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, eds. Mucosal Immunology. San Diego, CA: Academic Press; 1999:293-317.
9. Li J, Kudsk KA, Gocinski B, Dent D, Glezer J, Langkamp-Henken B. Effects of parenteral and enteral nutrition on gut-associated lymphoid tissue. J Trauma. 1995;39:44-51.
10. White RS, Fuqua WB, Barrett O Jr. The effect of 5-fluorouracil on small bowel mucosa. J Surg Oncol. 1971;3:501-506.
11. Jankovic L, Jelic S, Filipovic-Ljeskovic I, Ristovic Z. Salivary immunoglobulins in cancer patients with chemotherapy-related oral mucosa damage. Eur J Cancer B Oral Oncol. 1995;31B:160-165.
12. Harrison T, Bigler L, Tucci M, et al. Salivary sIgA concentrations and stimulated whole saliva flow rates among women undergoing chemotherapy for breast cancer: an exploratory study. Spec Care Dentist. 1998;18:109-112.
13. Sitren HS, Heller PA, Bailey LB, Cerda JJ. Total parenteral nutrition in the mouse: development of a technique. JPEN J Parenter Enteral Nutr. 1987;7:582-586.
14. Sanderson IR, Walker WA. Mucosal barrier. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, eds. Mucosal Immunology. San Diego, CA: Academic Press; 1999:5-17.
15. Johnson CD, Kudsk KA. Nutrition and intestinal mucosal immunity. Clin Nutr. 1999;18:337-344.
16. Kramer DR, Sutherland RM, Bao S, Husband AJ. Cytokine-mediated effects in mucosal immunity. Immunol Cell Biol. 1995;73:389-396.
17. Lefrancois L, Puddington L. Basic aspects of intraepithelial lymphocyte immunology. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, eds. Mucosal Immunology. San Diego, CA: Academic Press; 1999:413-428.
18. Pinedo HM, Peters GF. Fluorouracil: biochemistry and pharmacology. J Clin Oncol. 1988;6:1653-1664.
19. Bozzetti F. Nutritional support in cancer. In: Sobotka L, ed. Basics in Clinical Nutrition. Prague: Galen; 2000:239-247.
20. Chandra RK, Wadhwa M. Nutritional modulation of intestinal mucosal immunity: present knowledge and future directions. Lancet. 1983;26:688-691.
21. Wang J, Yang M, Yagi S, Hoffman RM. Oral 5-FU is a more effective antimetastatic agent than UFT. Anticancer Res. 2004;24:1353-1360.
22. Okamoto K, Fukatsu K, Ueno C, et al. T lymphocyte numbers in human gut associated lymphoid tissue are reduced without enteral nutrition. JPEN J Parenter Enteral Nutr. 2005;29:56-58.